Ether

Ether

SCHEMBL6430576

CCCCCNc1ccc(O)c2ccccc12.CCOCC

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 13/20 0.68
CHEK1 O14757 1/20 0.56
PIM1 P11309 1/20 0.56
LTK P29376 1/20 0.56
LIMK1 P53667 1/20 0.56
CLK4 Q9HAZ1 1/20 0.56
EP300 Q09472 2/20 0.52
CNR1 P21554 1/20 0.51
CNR2 P34972 1/20 0.51
KAT2B Q92831 1/20 0.44
KAT8 Q9H7Z6 1/20 0.44
GAA P10253 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4642633 0.93 IDO1 (0.78) IDO1CHEK1PIM1LTKLIMK1
SCHEMBL12599071 0.88 IDO1 (0.81) IDO1CHEK1PIM1LTKLIMK1
SCHEMBL30824997 0.88 IDO1 (0.81) IDO1CHEK1PIM1LTKLIMK1
SCHEMBL11337260 0.83 IDO1 (0.63) IDO1CHEK1PIM1LTKLIMK1
SCHEMBL6826422 0.82 IDO1 (0.61) IDO1CHEK1PIM1LTKLIMK1
SCHEMBL11404368 0.82 IDO1 (0.61) IDO1CHEK1PIM1LTKLIMK1
SCHEMBL11399348 0.82 IDO1 (0.61) IDO1CHEK1PIM1LTKLIMK1
SCHEMBL12599065 0.81 IDO1 (1.00) IDO1CHEK1PIM1LTKLIMK1
SCHEMBL11403032 0.79 IDO1 (0.65) IDO1CHEK1PIM1LTKLIMK1
SCHEMBL9464309 0.78 IDO1 (0.56) IDO1CHEK1PIM1LTKLIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050261498-A1 Preparation of 4-amino-1-naphthol ethers KOMOSCHINSKI JOACHIM 2005-11-24 US claimed
US-6964963-B2 Preparation of 4-amino-1-naphthol ethers BAYER AKTIENGESELLSCHAFT (DE) 2005-11-15 US claimed
US-20030083525-A1 Preparation of 4-amino-1-naphthol ethers LANXESS DEUTSCHLAND GMBH (DE) 2003-05-01 US claimed
US-20050261498-A1 Preparation of 4-amino-1-naphthol ethers KOMOSCHINSKI JOACHIM 2005-11-24 US disclosed
US-6964963-B2 Preparation of 4-amino-1-naphthol ethers BAYER AKTIENGESELLSCHAFT (DE) 2005-11-15 US disclosed
US-20030083525-A1 Preparation of 4-amino-1-naphthol ethers LANXESS DEUTSCHLAND GMBH (DE) 2003-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261498-A1 Preparation of 4-amino-1-naphthol ethers NAP1L4, NAAA, NPEPPS IDO1 1430/4885CHEK1 4511/4885PIM1 2591/4885
US-20030083525-A1 Preparation of 4-amino-1-naphthol ethers NAP1L4, NAAA, NPEPPS IDO1 1430/4885CHEK1 4511/4885PIM1 2591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.